Here is the CMT Uptime check phrase Skip to main content
site logo

Dr. Zivin studies intended and unintended consequences of policies that influence vulnerable populations with mental disorders, including older adults. Her research focuses on predictors and consequences of depression, particularly among vulnerable populations, including the elderly, people with multiple medical comorbidities and people who face barriers to accessing and adhering to depression treatment.

Dr. Maust’s research interests focus on ensuring that older adults with mental health and cognitive disorders receive targeted, timely, and appropriate intervention.

Dr. Langa’s research focuses on the epidemiology and costs of chronic disease in older adults, with an emphasis on Alzheimer’s disease and other dementias. Dr. Langa’s is currently studying the relationship of cardiovascular risk factors to cognitive decline and dementia in middle-age and older adults.  He serves as an Associate Director for the Health and Retirement Study (HRS) and as a MiCDA Advisory Panel Member.

Dr. Ehrlich is a clinician-scientist whose research on vision impairment cross-cuts population health and health services research. He has an interest in the health and disability trajectories of older adults with visual and multisensory impairments. He conducts research on low vision and vision rehabilitation; aging and vision; and the epidemiology of eye disease. As a co-investigator on the National Health and Aging Trends Study, he has collaborated on the design of a set of vision tests for use by interviewers in the home. He is also one of the PIs of the Longitudinal Study of Health and Ageing in Kenya (LOSHAK) project.

Dr. Bynum’s research focuses on the assessment of healthcare delivery for older adults using national U.S. Medicare healthcare data linked to other datasets. She has successfully led interdisciplinary teams to answer questions about the performance of the health system and the complex drivers of quality and costs, especially for older adults nearing the end of life or with Alzheimer’s disease.

Dr. Ware conducts high throughput statistical analysis of genomic data to study disparities by in psychiatric outcomes by race and sex. She also explores gene-environment interactions as determinants of chronic disease.